J&J Remains Committed to Supplying 200 Million Vaccine Doses to EU, Norway and Iceland
April 20 2021 - 12:51PM
Dow Jones News
By Josh Beckerman
Johnson & Johnson said it remains committed to supplying 200
million doses of its Covid-19 vaccine to the European Union, Norway
and Iceland.
Earlier Tuesday, the European Medicines Agency called for a
warning about very rare blood clots but said the benefits of the
vaccine outweigh the risks.
J&J said it will update the Summary of Product
Characteristics and Package Leaflet. "Healthcare professionals will
be alerted to the signs and symptoms of thromboembolism with
thrombocytopenia, as well as the appropriate course of treatment,"
the company said.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
April 20, 2021 12:36 ET (16:36 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Mar 2024 to Apr 2024
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Apr 2023 to Apr 2024
